发明名称 URETHANE DERIVATIVE
摘要 PROBLEM TO BE SOLVED: To obtain a medicinal composition having an excellent low density lipoprotein receptor gene expression-reinforcing action and useful for preventing and treating hyperlipemia, atherosclerosis, etc., by including a specific compound having a urethane skeleton. SOLUTION: This medicinal composition contains a compound, such as a urethane derivative of formula II [R<1> is a (substituted) heterocyclic group, etc.; R<2> is H, etc.; R<3> is a (substituted) alkyl, etc.], containing a urethane skeleton of formula I, having a low density lipoprotein receptor expression-reinforcing action, or its pharmacologically acceptable salt as an active ingredient. The compound of formula II includes (quinolin-3-yl) carbamic acid cyclopentyl ester obtained by reacting cyclopentanol with the reaction product of 3-aminoquinoline with N,N' -carbonyldiimidazole in the presence of an acid-removing agent in a solvent at -10 to 30 deg.C. The compound of formula II is preferably administered at a daily dose of about 5-20 mg/kg as an injection or at a daily dose of about 10-100 mg/kg as an oral agent.
申请公布号 JPH1135545(A) 申请公布日期 1999.02.09
申请号 JP19970195309 申请日期 1997.07.22
申请人 TANABE SEIYAKU CO LTD 发明人 HORIKAWA KOUSHI;FURUKUBO SHIGERU;YAMAGUCHI TETSUHISA;OMORI KENJI;ONUKI TETSUO;OGUCHI YASUSHI;ASAI YASUYUKI
分类号 C07D295/08;A61K31/27;A61K31/34;A61K31/341;A61K31/38;A61K31/381;A61K31/382;A61K31/385;A61K31/40;A61K31/4015;A61K31/403;A61K31/4035;A61K31/404;A61K31/415;A61K31/4184;A61K31/425;A61K31/428;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4427;A61K31/445;A61K31/454;A61K31/47;A61K31/496;A61K31/505;A61P3/06;A61P43/00;C07C271/06;C07D207/27;C07D209/16;C07D209/48;C07D213/36;C07D213/40;C07D215/54;C07D231/56;C07D235/30;C07D241/20;C07D277/82;C07D307/20;C07D307/52;C07D333/66;C07D335/06;C07D339/06;C07D401/12 主分类号 C07D295/08
代理机构 代理人
主权项
地址